Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) September 12 - 13, 2025!

For more Information and Register: Delaware ACC By the Sea: 2025 Chapter Meeting

Delaware Chapter of the American College of Cardiology


Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Rhythm Control May Improve Moderate-Severe/Severe Secondary TR
    Successful rhythm control of atrial fibrillation (AFib) was associated with improved secondary tricuspid regurgitation (STR) in patients with moderate-severe or severe STR, according to research published April 23 in JACC: Cardiovascular Imaging.
  • Poor Visual Acuity Associated With Cardiovascular, All-Cause Mortality Risk
    In a nationwide cohort of more than 2.5 million Chinese adults aged 65 years or older, visual acuity (VA) impairment was highly prevalent and independently associated with increased risk of mortality from any cause and from cardiovascular disease, according to a large-scale study published April 15 in JACC.
  • Hypertension Risk From Low-Level PM Exposure
    Long-term exposure to fine particulate matter ≤2.5 μm in diameter (PM2.5), which is below current regulatory thresholds in the U.S., may contribute to increased hypertension risk, according to a national cohort study published April 15 in JACC.
  • ORBITA Analysis: Microvascular Resistance Impacts PCI Benefit
    Patients with lower microvascular resistance (MVR) saw greater placebo-controlled benefit from PCI, according to a retrospective analysis of the ORBITA trial published April 29 in JACC: Cardiovascular Interventions.
  • BP Reduction Brings Comparable CV Benefits in CKD
    Patients with chronic kidney disease (CKD) enjoyed the same reduction in cardiovascular risk from lowering systolic blood pressure (SBP) as those without CKD, and this finding held across all CKD stages, BP thresholds, proteinuria status and antihypertensive class, according to research published April 25 in The Lancet.